Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al

Published by Luis Vitetta on

Related Posts

Medical

Cannabis Extract Effects on Metabolic Parameters and Gut Microbiota Composition in a Mice Model of NAFLD and Obesity

Evid Based Complement Alternat Med. 2022 Jun 26;2022:7964018. doi: 10.1155/2022/7964018. eCollection 2022. ABSTRACT Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver abnormalities and has been linked with metabolic syndrome hallmarks. Unfortunately, Read more…

Medical

Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions

Inflammopharmacology. 2022 Jul 7. doi: 10.1007/s10787-022-01020-z. Online ahead of print. ABSTRACT Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and insomnia. THC and CBD increase signaling Read more…

Medical

Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation

Integr Cancer Ther. 2022 Jan-Dec;21:15347354221096766. doi: 10.1177/15347354221096766. ABSTRACT The efficacy of chemotherapy depends on the tumor microenvironment. This microenvironment consists of a complex cellular network that can exert both stimulatory and inhibitory effects on tumor Read more…

error: Content is protected !!